FDA
approval
· 2022-01-26
FDA Approved: SOLOSEC — Supplemental Application (Evofem Inc.)
Summary
The FDA approved a supplemental application for SoLOSEC (secnidazole) from Evofem Inc., expanding the product's labeling/indication.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for SOLOSEC (SECNIDAZOLE)